Immunohistochemical staining revealed that the expression levels of CD-31 and PTPN12 in tumor tissues were significantly increased in the group treated with sEVs, whereas these levels were significantly decreased in the group treated with the miR-494-3p inhibitor (Fig. 8G). This evidence concerns the gene PECAM1 and neoplasm.